ArticlePediatric surgery international2026
Scarless thyroid surgery in children: a pediatric TOETVA cohort for differentiated thyroid carcinoma.
Article in Pediatric surgery international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background/purposeConventional open thyroidectomy leaves a visible cervical scar that can adversely affect the psychosocial well-being of pediatric patients. The transoral endoscopic thyroidectomy vestibular approach (TOETVA) offers a scarless alternative, but data regarding its application in pediatric malignancies remain scarce. This study aims to evaluate the surgical, cosmetic outcomes of TOETVA in pediatric patients with differentiated thyroid carcinoma (DTC).
methodsWe retrospectively reviewed consecutive pediatric patients ([Formula: see text] 18 years) who underwent TOETVA for DTC (cT1N0M0) at a high-volume center between June 2020 and June 2026. Postoperative complications and cosmetic satisfaction were evaluated.
resultsTwenty-six patients (mean age: 16.7 ± 1.9 years; 84.6% female) were enrolled. All procedures were successfully completed with a 0% conversion rate to open surgery. Twenty-four patients (92.3%) underwent thyroid lobectomy with isthmusectomy and prophylactic central neck dissection (CND) (mean operative time: 87.9 ± 9.5 min), while two (7.7%) underwent total thyroidectomy with CND (mean operative time: 132.5 min). Final histopathology confirmed papillary thyroid carcinoma in all cases. No major perioperative complications occurred. Transient adverse events included minor chin ecchymosis (11.5%), hoarseness (7.7%), and mental nerve injury (7.7%), all resolving completely within 3 months. No permanent recurrent laryngeal nerve injury, mental nerve dysfunction, or hypocalcemia was observed. Cosmetic outcomes were highly favorable, with all patients expressing excellent post-operative aesthetic satisfaction.
conclusionsTOETVA appears to be a safe and feasible surgical approach for carefully selected pediatric patients with DTC. In this largest reported pediatric TOETVA series to date, the procedure achieved favorable surgical and cosmetic outcomes with low complication rates. TOETVA may therefore represent an effective scarless alternative for selected pediatric thyroid cancer when performed by experienced surgeons in high-volume centers.
Indexed as
Identifiers
42536185What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.